Skip to main content
Equibles
INSP logo

INSP · Inspire Medical Systems, Inc. · Earnings Call Transcripts & Audio

Track INSP — free

Use INSP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INSP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$69.36 -3.82 (-5.22%) At close · Sep 30
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.04B
Shares
28.91M
Volume · Sep 30 1M Avg daily vol (3M) 805.14K

Inspire Medical Systems, Inc. Earnings Call Transcripts

Quarterly earnings calls for Inspire Medical Systems, Inc. (INSP), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲77% $109.19M −$16.85M '22 Q3 22-11-01 ▲75.9% $137.90M $3.15M '22 Q4 23-02-07 ▲84.3% $127.90M −$15.42M '23 Q1 23-05-02 ▲65.3% $151.09M −$11.95M '23 Q2 23-08-01 ▲40.4% $153.30M −$8.54M '23 Q3 23-11-07 ▲39.6% $192.51M $14.76M '23 Q4 24-02-06 ▲28.2% $164.01M −$10.01M '24 Q1 24-05-07 ▲29.6% $195.88M $9.79M '24 Q2 24-08-06 ▲32.5% $203.19M $18.50M '24 Q3 24-11-04 ▲24.5% $239.72M $35.22M '24 Q4 25-02-10 ▲22.7% $201.32M $2.99M '25 Q1 25-05-05 ▲10.8% $217.09M −$3.59M '25 Q2 25-08-04 ▲10.5% $224.50M $9.93M '25 Q3 25-11-03 ▲12.2% $269.08M $136.09M '25 Q4 26-02-11 ▲1.6% $204.58M −$11.29M '26 Q1 26-05-04 LATEST ▼7.6% $200.58M $314,000 '26 Q2 26-08-03
Conference
Investor event
2026-09-09
Inspire Medical Systems, Inc. (INSP) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-03
Inspire Medical Systems, Inc. (INSP) Q2 2026 Earnings Call
Revenue
$200.58M
▼ 7.6% YoY
Diluted EPS
$0.01
Gross margin
85.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-04
Inspire Medical Systems, Inc. (INSP) Q1 2026 Earnings Call Transcript
Cautious tone Coding and reimbursement challenges for Inspire V WISER government prior authorization program Long-term CPT code path effective 2028
Revenue
$204.58M
▲ 1.6% YoY
Diluted EPS
$-0.39
▼ 490% YoY
Gross margin
86.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-11
Inspire Medical Systems, Inc. (INSP) Q4 2025 Earnings Call Transcript
Cautious tone Inspire 5 coding and reimbursement Inspire 5 launch and clinical performance WISER prior authorization program
Revenue
$269.08M*
▲ 12.2% YoY
Gross margin
86.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Inspire Medical Systems, Inc. (INSP) Q3 2025 Earnings Call Transcript
Confident tone Inspire V Launch and Adoption Revenue and Earnings Guidance GLP-1 Drugs and Patient Funnel
Revenue
$224.50M
▲ 10.5% YoY
Diluted EPS
$0.34
▼ 43.3% YoY
Gross margin
85.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Inspire Medical Systems, Inc. (INSP) Q2 2025 Earnings Call Transcript
Cautious tone Inspire V Commercial Rollout Challenges Revised Full Year 2025 Guidance CPT Code 64568 / Medicare Reimbursement
Revenue
$217.09M
▲ 10.8% YoY
Diluted EPS
$-0.12
▼ 137.5% YoY
Gross margin
84.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Inspire Medical Systems, Inc. (INSP) Q1 2025 Earnings Call Transcript
Confident tone Inspire V full launch International expansion Medical education and provider capacity
Revenue
$201.32M
▲ 22.7% YoY
Diluted EPS
$0.10
Gross margin
84.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-10
Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript
Confident tone Inspire V product launch and ramp Financial performance and 2025 guidance Medical education and provider training
Revenue
$239.72M*
▲ 24.5% YoY
Gross margin
85.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Inspire Medical Systems, Inc. (INSP) Q3 2024 Earnings Call Transcript
Confident tone Inspire V product launch Revenue growth and guidance raise SleepSync and digital initiatives
Revenue
$203.19M
▲ 32.5% YoY
Diluted EPS
$0.60
Gross margin
84.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Inspire Medical Systems, Inc. (INSP) Q2 2024 Earnings Call Transcript
Confident tone Revenue growth and guidance raise EU MDR certification and France reimbursement U.S. commercial expansion
Revenue
$195.88M
▲ 29.6% YoY
Diluted EPS
$0.32
Gross margin
84.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Inspire Medical Systems, Inc. (INSP) Q1 2024 Earnings Call Transcript
Confident tone GLP-1 complementary positioning Direct-to-consumer and medical education Product innovation and pipeline
Revenue
$164.01M
▲ 28.2% YoY
Diluted EPS
$-0.34
Gross margin
84.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-06
Inspire Medical Systems, Inc. (INSP) Q4 2023 Earnings Call Transcript
Confident tone Revenue growth and 2024 guidance GLP-1 and patient pipeline Operating income and profitability
Revenue
$192.51M*
▲ 39.6% YoY
Gross margin
85.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Inspire Medical Systems, Inc. (INSP) Q3 2023 Earnings Call Transcript
Revenue
$153.30M
▲ 40.4% YoY
Diluted EPS
$-0.29
Gross margin
84.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Inspire Medical Systems, Inc. (INSP) Q2 2023 Earnings Call Transcript
Revenue
$151.09M
▲ 65.3% YoY
Diluted EPS
$-0.41
Gross margin
83.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Inspire Medical Systems, Inc. (INSP) Q1 2023 Earnings Call Transcript
Revenue
$127.90M
▲ 84.3% YoY
Diluted EPS
$-0.53
Gross margin
84.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-07
Inspire Medical Systems, Inc. (INSP) Q4 2022 Earnings Call Transcript
Revenue
$137.90M*
▲ 75.9% YoY
Gross margin
83.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Inspire Medical Systems, Inc. (INSP) Q3 2022 Earnings Call Transcript
Revenue
$109.19M
▲ 77% YoY
Diluted EPS
$-0.60
Gross margin
81.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Inspire Medical Systems, Inc. (INSP) Q2 2022 Earnings Call Transcript
Revenue
$91.39M
▲ 72.6% YoY
Diluted EPS
$-0.53
Gross margin
84.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Inspire Medical Systems, Inc. (INSP) Q1 2022 Earnings Call Transcript
Revenue
$69.38M
▲ 71.9% YoY
Diluted EPS
$-0.61
Gross margin
85.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-18
Inspire Medical Systems, Inc. (INSP) Q4 2021 Earnings Call Transcript
Revenue
$78.40M*
▲ 70.4% YoY
Gross margin
85.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Inspire Medical Systems, Inc. (INSP) Q3 2021 Earnings Call Transcript
Revenue
$61.69M
▲ 72.1% YoY
Diluted EPS
$-0.38
Gross margin
86.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Inspire Medical Systems, Inc. (INSP) Q2 2021 Earnings Call Transcript
Revenue
$52.96M
▲ 334.7% YoY
Diluted EPS
$-0.48
Gross margin
85.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Inspire Medical Systems, Inc. (INSP) Q1 2021 Earnings Call Transcript
Revenue
$40.35M
▲ 89% YoY
Diluted EPS
$-0.60
Gross margin
85.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-23
Inspire Medical Systems, Inc. (INSP) Q4 2020 Earnings Call Transcript
Revenue
$46.01M
▲ 71% YoY
Gross margin
84.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-02
Inspire Medical Systems, Inc. (INSP) Q3 2020 Earnings Call Transcript
Revenue
$35.84M
▲ 71.8% YoY
Diluted EPS
$-0.39
Gross margin
85.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Inspire Medical Systems, Inc. (INSP) Q2 2020 Earnings Call Transcript
Revenue
$12.18M
▼ 32.4% YoY
Diluted EPS
$-0.88
Gross margin
84.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Inspire Medical Systems, Inc. (INSP) Q1 2020 Earnings Call Transcript
Revenue
$21.35M
▲ 31.4% YoY
Gross margin
84.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Inspire Medical Systems, Inc. (INSP) Q4 2019 Earnings Call
Revenue
$26.91M
▲ 62.5% YoY
Gross margin
84.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 earnings calls
Key facts CIK 1609550 CUSIP 457730109 13F (30d) 9 filings 7 filers Visit website Investor relations